MedPath

Jiangsu Carephar Pharmaceutical Co., Ltd.

Jiangsu Carephar Pharmaceutical Co., Ltd. logo
πŸ‡¨πŸ‡³China
Ownership
Private
Established
2006-06-08
Employees
-
Market Cap
-
Website
http://www.carephar.com

A Study of Single and Multiple Ascending Doses of H021 in Healthy Participants

Phase 1
Recruiting
Conditions
Ulcerative Colitis
Interventions
Drug: H021 Placebo
First Posted Date
2024-10-04
Last Posted Date
2024-10-04
Lead Sponsor
Jiangsu Carephar Pharmaceutical Co., Ltd.
Target Recruit Count
64
Registration Number
NCT06627556
Locations
πŸ‡¦πŸ‡Ί

Nucleus Network Ply Ltd., Melbourne, Victoria, Australia

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of Oral Doses of H008

Phase 1
Completed
Conditions
Erosive Esophagitis
Interventions
First Posted Date
2021-09-20
Last Posted Date
2023-12-15
Lead Sponsor
Jiangsu Carephar Pharmaceutical Co., Ltd.
Target Recruit Count
24
Registration Number
NCT05050188
Locations
πŸ‡ΊπŸ‡Έ

Syneos Health, Miami, Florida, United States

Β© Copyright 2025. All Rights Reserved by MedPath